Cargando…
Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
BACKGROUND: The efficacy of direct-acting antivirals (DAAs) depends on the hepatitis C virus (HCV) genotype 4 (GT4) subtype which are used in the treatment of HCV. We aimed to retrospectively investigate the baseline prevalence of HCV NS5A and NS5B polymorphisms and their impact on virological outco...
Autores principales: | Minosse, Claudia, Selleri, Marina, Giombini, Emanuela, Bartolini, Barbara, Capobianchi, Maria Rosaria, Cerilli, Stefano, Loiacono, Laura, Taibi, Chiara, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, AnnaRosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223400/ https://www.ncbi.nlm.nih.gov/pubmed/30464554 http://dx.doi.org/10.2147/IDR.S179158 |
Ejemplares similares
-
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
por: Bartolini, Barbara, et al.
Publicado: (2017) -
Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021) -
Anti-HEV IgG Avidity Testing: Utility for Diagnosing Acute and Resolved Genotype 3 Infections
por: Minosse, Claudia, et al.
Publicado: (2021) -
Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
por: Lapa, Daniele, et al.
Publicado: (2021) -
Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
por: Minosse, Claudia, et al.
Publicado: (2021)